53 related articles for article (PubMed ID: 10961684)
1. Inhibitory effects of pentamidine analogues on protein biosynthesis in vitro.
Bielawski K; Galicka A; Bielawska A; Sredzińska K
Acta Biochim Pol; 2000; 47(1):113-20. PubMed ID: 10961684
[TBL] [Abstract][Full Text] [Related]
2. High hydrostatic pressure inhibits the biosynthesis of eukaryotic elongation factor-2.
Elo MA; Karjalainen HM; Sironen RK; Valmu L; Redpath NT; Browne GJ; Kalkkinen N; Helminen HJ; Lammi MJ
J Cell Biochem; 2005 Feb; 94(3):497-507. PubMed ID: 15534876
[TBL] [Abstract][Full Text] [Related]
3. Possibility of the transformation of eEF-2 (100 kDa) to eEF-2 (65 kDa) in the peptide elongation process in vitro.
Gajko A; Sredzińska K; Galasiński W; Gindzieński A
Biochem Biophys Res Commun; 1999 Feb; 255(2):535-8. PubMed ID: 10049743
[TBL] [Abstract][Full Text] [Related]
4. The influence of selected potential oncostatics of plant origin on the protein biosynthesis in vitro.
Paszkiewicz-Gadek A; Chlabicz J; Gałasiński W
Pol J Pharmacol Pharm; 1988; 40(2):183-90. PubMed ID: 3237568
[TBL] [Abstract][Full Text] [Related]
5. Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment.
Ergen K; Bektaş M; Gökçe S; Nurten R
Biocell; 2007; 31(1):61-6. PubMed ID: 17665640
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, anti-Trypanosoma cruzi activity and micelle interaction studies of bisguanylhydrazones analogous to pentamidine.
Borges MN; Messeder JC; Figueroa-Villar JD
Eur J Med Chem; 2004 Nov; 39(11):925-9. PubMed ID: 15501541
[TBL] [Abstract][Full Text] [Related]
7. Elongation factor 2 as a target for selective inhibition of protein synthesis in vitro by the novel aromatic bisamidine.
Gajko-Galicka A; Bielawski K; Sredzinska K; Bielawska A; Gindzienski A
Mol Cell Biochem; 2002 Apr; 233(1-2):159-64. PubMed ID: 12083371
[TBL] [Abstract][Full Text] [Related]
8. 2-Deoxyglucose and NMDA inhibit protein synthesis in neurons and regulate phosphorylation of elongation factor-2 by distinct mechanisms.
Maus M; Torrens Y; Gauchy C; Bretin S; Nairn AC; Glowinski J; Premont J
J Neurochem; 2006 Feb; 96(3):815-24. PubMed ID: 16405506
[TBL] [Abstract][Full Text] [Related]
9. 'In vitro' protective effect of a hydrophilic vitamin E analogue on the decrease in levels of elongation factor 2 in conditions of oxidative stress.
Argüelles S; Machado A; Ayala A
Gerontology; 2007; 53(5):282-8. PubMed ID: 17510559
[TBL] [Abstract][Full Text] [Related]
10. Effect of the components extracted from the needles of Taxus baccata on protein biosynthesis in a cell-free rat liver system.
Sredzińska K; Gajko A; Gałasiński W; Gindzieński A
Acta Pol Pharm; 1999; 56(1):29-33. PubMed ID: 10635350
[TBL] [Abstract][Full Text] [Related]
11. Effects of netropsin and pentamidine amino analogues on the amidolytic activity of plasmin, trypsin and urokinase.
Pućkowska A; Midura-Nowaczek K; Bruzgo I
Acta Pol Pharm; 2008; 65(2):213-5. PubMed ID: 18666427
[TBL] [Abstract][Full Text] [Related]
12. The substances of plant origin that inhibit protein biosynthesis.
Gałasiński W; Chlabicz J; Paszkiewicz-Gadek A; Marcinkiewicz C; Gindzieński A
Acta Pol Pharm; 1996; 53(5):311-8. PubMed ID: 9415207
[TBL] [Abstract][Full Text] [Related]
13. Anti-plasmodial and anti-leishmanial activity of conformationally restricted pentamidine congeners.
Huang TL; Vanden Eynde JJ; Mayence A; Donkor IO; Khan SI; Tekwani BL
J Pharm Pharmacol; 2006 Aug; 58(8):1033-42. PubMed ID: 16872549
[TBL] [Abstract][Full Text] [Related]
14. Dual regulation of translation initiation and peptide chain elongation during BDNF-induced LTP in vivo: evidence for compartment-specific translation control.
Kanhema T; Dagestad G; Panja D; Tiron A; Messaoudi E; Håvik B; Ying SW; Nairn AC; Sonenberg N; Bramham CR
J Neurochem; 2006 Dec; 99(5):1328-37. PubMed ID: 17064361
[TBL] [Abstract][Full Text] [Related]
15. Trypanocidal activity of conformationally restricted pentamidine congeners.
Donkor IO; Huang TL; Tao B; Rattendi D; Lane S; Vargas M; Goldberg B; Bacchi C
J Med Chem; 2003 Mar; 46(6):1041-8. PubMed ID: 12620080
[TBL] [Abstract][Full Text] [Related]
16. Translation regulation after taxol treatment in NIH3T3 cells involves the elongation factor (eEF)2.
Piñeiro D; González VM; Hernández-Jiménez M; Salinas M; Martín ME
Exp Cell Res; 2007 Oct; 313(17):3694-706. PubMed ID: 17825817
[TBL] [Abstract][Full Text] [Related]
17. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
Parikh SL; Schramm VL
Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiprotozoal activity of pyridyl analogues of pentamidine.
Bakunova SM; Bakunov SA; Wenzler T; Barszcz T; Werbovetz KA; Brun R; Tidwell RR
J Med Chem; 2009 Aug; 52(15):4657-67. PubMed ID: 19606902
[TBL] [Abstract][Full Text] [Related]
19. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
Bektaş M; Nurten R; Ergen K; Bermek E
Cell Biochem Funct; 2006; 24(4):369-80. PubMed ID: 16142694
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity study of pentamidine analogues as antiprotozoal agents.
Bakunova SM; Bakunov SA; Patrick DA; Kumar EV; Ohemeng KA; Bridges AS; Wenzler T; Barszcz T; Jones SK; Werbovetz KA; Brun R; Tidwell RR
J Med Chem; 2009 Apr; 52(7):2016-35. PubMed ID: 19267462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
